-
inherited cardiac disorders, including cardiomyopathies and primary electrical disorders that occur in the absence of structural abnormalities of the heart. These conditions are linked to SCD in young
-
prevalent group (mutations in STXBP1), and to design intervention strategies. Our research is developed within the framework of a European consortium, ESCO, where scientists, clinicians, patient families and
-
be more likely to react to chemotherapy than a tumour that is not perfused, as the chemo will need to reach the tumour. As personalizing a treatment based on such biomarkers can substantially improve
Searches related to structure based drug design
Enter an email to receive alerts for structure-based-drug-design positions